tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Lichen Nitidus D017513 1 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Mucinoses D017520 2 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Lichen Planus, Oral D017676 2 associated lipids
Cytomegalovirus Retinitis D017726 2 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Glucose Intolerance D018149 13 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Cardiovirus Infections D018188 3 associated lipids
Fibroadenoma D018226 2 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Seminoma D018239 2 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Angiofibroma D018322 2 associated lipids
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Lichen Sclerosus et Atrophicus D018459 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cryptogenic Organizing Pneumonia D018549 3 associated lipids
Hypoplastic Left Heart Syndrome D018636 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Fasciitis, Necrotizing D019115 1 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Oral Ulcer D019226 1 associated lipids
Endotoxemia D019446 27 associated lipids
Pouchitis D019449 3 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Citrullinemia D020159 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Trauma, Nervous System D020196 2 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Hypertensive Encephalopathy D020343 1 associated lipids
Paraneoplastic Syndromes, Nervous System D020361 1 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Nervous System Autoimmune Disease, Experimental D020721 3 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Brachial Plexus Neuritis D020968 2 associated lipids
Lacerations D022125 1 associated lipids
Coronary Stenosis D023921 6 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Papillomavirus Infections D030361 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Cholecystolithiasis D041761 2 associated lipids
Intestinal Volvulus D045822 1 associated lipids
Ileus D045823 3 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Renal Insufficiency D051437 8 associated lipids
Delayed Graft Function D051799 2 associated lipids
Nocturia D053158 1 associated lipids
Dysuria D053159 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Lee YH and Song GG Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials. 2015 Lupus pmid:26162684
Liao R et al. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis. 2015 PLoS ONE pmid:26161538
Dury S et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. 2015 BMC Pulm Med pmid:26545860
Kanchongkittiphon W et al. Child with atopic dermatitis. 2015 Ann. Allergy Asthma Immunol. pmid:25528736
Obayashi N et al. Management of tacrolimus-associated food allergy after liver transplantation. 2015 Pediatr Int pmid:26541649
Kwon M et al. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. 2015 Arch. Pharm. Res. pmid:24627339
Velickovic-Radovanovic R et al. Gender-dependent predictable pharmacokinetic method for tacrolimus exposure monitoring in kidney transplant patients. 2015 Eur J Drug Metab Pharmacokinet pmid:24596067
Hu L et al. Severe Tacrolimus-Induced Granulomatous Rosacea Recalcitrant to Oral Tetracyclines. 2015 J Drugs Dermatol pmid:26091390
Melilli E et al. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring. 2015 Transpl. Int. pmid:26088437
Traitanon O et al. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. 2015 PLoS ONE pmid:26087255
Seo YG et al. Solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability of poorly water-soluble tacrolimus: physicochemical characterisation and pharmacokinetics. 2015 J Microencapsul pmid:26079598
Boukoum H et al. BK and JC polyomavirus infections in Tunisian renal transplant recipients. 2015 J. Med. Virol. pmid:25952258
Hu WX et al. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. 2015 Lupus pmid:25819933
Miura M et al. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. 2015 Nephrology (Carlton) pmid:26031588
Yagisawa T et al. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity. 2015 Nephrology (Carlton) pmid:26031587
Lee J et al. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. 2015 J. Korean Med. Sci. pmid:26028917
Mabuchi M et al. Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506. 2015 Bioorg. Med. Chem. Lett. pmid:26025877
Zhang D et al. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus. 2015 Mol. Pharm. pmid:26024817
Considine A et al. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts. 2015 Liver Transpl. pmid:25312292
Huang G et al. [Analysis on BK virus associated nephropathy related risk factors in renal transplant recipients]. 2015 Zhonghua Yi Xue Za Zhi pmid:26814103
Taber DJ et al. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. 2015 Pharmacotherapy pmid:26011276
Grammatikopoulos T et al. Anti-CD20 Monoclonal Antibody Therapy in Functional Bile Salt Export Pump Deficiency After Liver Transplantation. 2015 J. Pediatr. Gastroenterol. Nutr. pmid:24231640
Lim EJ et al. Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation. 2015 PLoS ONE pmid:26390404
Shu WY et al. Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population. 2015 Acta Pharmacol. Sin. pmid:25891088
Baird K et al. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. 2015 Biol. Blood Marrow Transplant. pmid:25771402
Shuker N et al. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure. 2015 Ther Drug Monit pmid:25265255
Soto GAC et al. Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration. 2015 Eur. J. Clin. Pharmacol. pmid:25953736
Leyking S et al. Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients. 2015 J Transl Med pmid:25885792
Wang X et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial. 2015 J Clin Pharmacol pmid:25951426
Ozbek OY and Ozcay F Long-term outcome of food allergy after liver transplantation in children. 2015 Pediatr Transplant pmid:25882294
Mistry NP et al. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. 2015 J. Pharm. Pharmacol. pmid:25944126
Banhara PB et al. Tubular dysfunction in renal transplant patients using sirolimus or tacrolimus. 2015 Clin. Nephrol. pmid:25943142
Rojas L et al. Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies. 2015 Pharmacogenomics J. pmid:25201288
Ding L et al. Clinical Immunosuppressants Inhibit Inflammatory, Proliferative, and Reprogramming Potential, But Not Angiogenesis of Human Pancreatic Duct Cells. 2015 Cell Transplant pmid:25198311
Zhou X et al. Effect of immunosuppression on the human mesangial cell cycle. 2015 Mol Med Rep pmid:25370945
Ã…berg F et al. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. 2015 Transplant. Proc. pmid:26680092
Rojanathammanee L et al. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition. 2015 J Neuroinflammation pmid:25889879
Peccerillo F et al. Eosinophilic cellulitis. 2015 G Ital Dermatol Venereol pmid:25946678
Størset E et al. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. 2015 Transplantation pmid:25886918
Montero N and Pascual J Immunosuppression and Post-transplant Hyperglycemia. 2015 Curr Diabetes Rev pmid:25824238
Reig Mezquida JP et al. Thrombotic microangiopathy associated with tacrolimus in lung transplantation. 2015 Arch. Bronconeumol. pmid:25138798
Seo YG et al. Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system. 2015 Arch. Pharm. Res. pmid:25134927
Nagashima T and Minota S Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. 2015 Rheumatology (Oxford) pmid:25832615
Vollmar J et al. Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan and Mowel after liver transplantation. 2015 Drug Des Devel Ther pmid:26604701
Yasuda S et al. Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply. 2015 Rheumatology (Oxford) pmid:25832614
Eichenfield DZ and Eichenfield LF Pimecrolimus is safe and effective in treating atopic dermatitis. 2015 J. Pediatr. pmid:26603713
Calabrese B and Halpain S Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity. 2015 Mol. Cell. Neurosci. pmid:25827095
Li Z et al. Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. 2015 PLoS ONE pmid:26599323
Madariaga ML et al. Kidney-induced cardiac allograft tolerance in miniature swine is dependent on MHC-matching of donor cardiac and renal parenchyma. 2015 Am. J. Transplant. pmid:25824550
Wang YY et al. Biochemical characterization of a malonyl-specific acyltransferase domain of FK506 biosynthetic polyketide synthase. 2015 Protein Pept. Lett. pmid:25267255
Chhatrala R et al. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers. 2015 Liver Transpl. pmid:25762084
Cendales L et al. Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. 2015 Am. J. Transplant. pmid:25773260
Soylu H et al. Survival of renal transplant patients: data from a tertiary care center in Turkey. 2015 Transplant. Proc. pmid:25769571
Helmschrott M et al. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation. 2015 Drug Des Devel Ther pmid:25759566
Singh N et al. Extended release once a day tacrolimus. 2015 Curr Opin Organ Transplant pmid:26536429
Ohe M and Bohgaki T A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. 2015 Bull Hosp Jt Dis (2013) pmid:26535602
Xiao A et al. H2S, a novel gasotransmitter, involves in gastric accommodation. 2015 Sci Rep pmid:26531221
Abdel-Azim H et al. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 2015 Am. J. Hematol. pmid:26242764
Liu X et al. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. 2015 Drug Metab. Dispos. pmid:25587129
Zitelli K et al. Eosinophilic folliculitis occurring after stem cell transplant for acute lymphoblastic leukemia: a case report and review. 2015 Int. J. Dermatol. pmid:25039354
Guethoff S et al. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results. 2015 J. Heart Lung Transplant. pmid:25701373
Pensi D et al. An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. 2015 J Pharm Biomed Anal pmid:25698619
Ceulemans LJ et al. Nonsteroidal anti-inflammatory drug-induced intestinal graft loss 12 years after transplantation. 2015 Transplantation pmid:25695790
Roche NA et al. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation. 2015 J Craniofac Surg pmid:26468783
Blažič M et al. Roles of the crotonyl-CoA carboxylase/reductase homologues in acetate assimilation and biosynthesis of immunosuppressant FK506 in Streptomyces tsukubaensis. 2015 Microb. Cell Fact. pmid:26466669
Wang JY and Fan H P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus. 2015 Chin. Med. J. pmid:25698201
Ferjani H et al. Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect? 2015 Hum Exp Toxicol pmid:25645822
Rodríguez-Perálvarez M et al. Everolimus is safe within the first month after liver transplantation. 2015 Transpl. Immunol. pmid:26392195
Van Driest SL and Webber SA Pharmacogenomics: personalizing pediatric heart transplantation. 2015 Circulation pmid:25645611
Ishida K et al. Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus. 2015 Drugs R D pmid:26386566
Chow SP et al. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression. 2015 Cornea pmid:26382894
Lin NC et al. Minimization or withdrawal of immunosuppressants in pediatric liver transplant recipients. 2015 J. Pediatr. Surg. pmid:26377868
Garcia MF et al. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. 2015 Int Urol Nephrol pmid:26377496
Ogul H et al. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. 2015 Acta Neurol Belg pmid:24854146
Tsujiwaki M et al. Warty intralymphatic histiocytosis successfully treated with topical tacrolimus. 2015 J Eur Acad Dermatol Venereol pmid:24851952
Fukushima D et al. Epstein-Barr virus--associated posttransplantation lymphoproliferative disorder with tacrolimus metabolism deterioration in infants after living-donor liver transplantation. 2015 Transplantation pmid:24846306
Pallet N et al. Kidney transplant recipients carrying the CYP3A4*22 allelic variant have reduced tacrolimus clearance and often reach supratherapeutic tacrolimus concentrations. 2015 Am. J. Transplant. pmid:25588704
Elbadri A et al. Factors affecting eGFR 5-year post-deceased donor renal transplant: analysis and predictive model. 2015 Ren Fail pmid:25585951
Krystel-Whittemore M et al. Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. 2015 BMJ Case Rep pmid:26318171
Saint-Marcoux F et al. How to handle missed or delayed doses of tacrolimus in renal transplant recipients? A pharmacokinetic investigation. 2015 Pharmacol. Res. pmid:26316426
Karam S and Wali RK Current State of Immunosuppression: Past, Present, and Future. 2015 Crit. Rev. Eukaryot. Gene Expr. pmid:26080606
Offer K et al. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. 2015 Biol. Blood Marrow Transplant. pmid:25536217
Ramachandran R et al. Role of Tacrolimus only therapy in modified Ponticelli regimen resistant idiopathic membranous glomerulonephritis. 2015 Nephrology (Carlton) pmid:25535867
Aikawa Y et al. Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells. 2015 Cancer Sci. pmid:25529853
Ãœnal CM and Steinert M FKBPs in bacterial infections. 2015 Biochim. Biophys. Acta pmid:25529296
Higa M et al. Spatial control of calcineurin in response to heat shock in fission yeast. 2015 Genes Cells pmid:25529221
Joshi S et al. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal. 2015 Epilepsia pmid:26248944
Duvoux C et al. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection. 2015 Ann. Transplant. pmid:25588713
Lim SW et al. Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury. 2015 Lab. Invest. pmid:26237274
Vaeth M et al. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25583478
Hoerning A et al. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. 2015 Transplantation pmid:25099702
Wu B et al. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. 2015 Nephrology (Carlton) pmid:25312783
Valke LL et al. Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation. 2015 Transpl. Immunol. pmid:25446808
Huang G et al. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis. 2015 Diagn. Microbiol. Infect. Dis. pmid:25445121
Namvaran F et al. The Effect of Tacrolimus on Reactive Oxygen Species and Total Antioxidant Status in Pancreatic Beta Cell Line. 2015 Exp Clin Transplant pmid:25431882
Spiekerkoetter E et al. Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. 2015 Am. J. Respir. Crit. Care Med. pmid:26177174
Mandelbrot DA et al. Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus. 2015 Am. J. Transplant. pmid:26176342
Guo CL et al. Efficacy of Topical Tacrolimus for Erosive Oral Lichen Planus: A Meta-analysis. 2015 Chin. Med. Sci. J. pmid:26960301
Apalla Z et al. Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature. 2015 Actas Dermosifiliogr pmid:26164836
Vives R et al. Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial. 2015 Clin Ther pmid:26163200